Veracyte (VCYT) Inventory (2012 - 2025)

Veracyte has disclosed Inventory across 14 years of filings, most recently posting $20.5 million for Q4 2025.

• Inventory for Q4 2025 came in at $20.5 million, down 5.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.5 million (down 5.54% YoY), and the FY2025 annual result was $20.5 million, down 5.54% from the prior year.
• Inventory came in at $20.5 million for Q4 2025 at Veracyte, up from $20.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $25.0 million in Q2 2025 to a low of $6.3 million in Q1 2021.
• The 5-year median for Inventory is $15.2 million (2022), against an average of $15.8 million.
• Across the five-year window, Inventory surged 141.04% in 2021 and retreated 20.74% in 2023, its largest moves.
• Veracyte's Inventory stood at $11.2 million in 2021, then increased by 27.34% to $14.3 million in 2022, then rose by 12.83% to $16.1 million in 2023, then jumped by 34.86% to $21.8 million in 2024, then decreased by 5.54% to $20.5 million in 2025.
• The last three Inventory figures came in at $20.5 million (Q4 2025), $20.3 million (Q3 2025), and $25.0 million (Q2 2025), per Business Quant data.